Pure Global

Gastroparesis symptoms and its treatment using low-viscosity soluble dietary fibres - Trial ANZCTR12621001646831

Access comprehensive clinical trial information for ANZCTR12621001646831 through Pure Global AI's free database. This Not Applicable trial is sponsored by Western Sydney University and is currently Completed. The study focuses on Gastroparesis.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ANZCTR12621001646831
Not Applicable
Completed
other
Trial Details
Australian New Zealand Clinical Trials Registry โ€ข ANZCTR12621001646831
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Gastroparesis symptoms and its treatment using low-viscosity soluble dietary fibres
The Short-Term Effects and Tolerability of Low-Viscosity Soluble Fibre on Gastroparesis Patients: A Pilot Clinical Intervention Study

Study Focus

Gastroparesis

Interventional

other

Sponsor & Location

Western Sydney University

Australia

Timeline & Enrollment

Not Applicable

Jul 02, 2018

Feb 05, 2020

Primary Outcome

To compare the blood glucose regulation / control ability of 'low-viscosity' test fibres Partially-hydrolysed guar gum (PHGG) and Gum Arabic to the negative control (Water) and positive control (Psyllium Husk). The blood glucose control of the interventions was assessed using pin-prick blood glucose values in response to the interventions, Actilax and the glucose challenge (50 g in 300 mL).;; To compare the symptom severity / tolerability of 'low-viscosity' test fibres Partially-hydrolysed guar gum (PHGG) and Gum Arabic to the negative control (Water) and positive control (Psyllium Husk). The tolerability of the interventions was assessed using the patient-rated American Neurogastroenterology and Motility Society - Gastroparesis Cardinal Symptom Index - Daily Diary (ANMS-GCSI-DD) in response to the interventions, Actilax and the glucose challenge (50 g in 300 mL).

Summary

The principal aim of this clinical study was to determine the short-term blood-glucose control and tolerability of Partially-hydrolysed guar gum (PHGG) and Gum Arabic in mild-to-moderate symptom gastroparesis patients. There were four interventions in total, the test fibres PHGG and Gum Arabic, the positive control Psyllium Husk and the negative control Water. The study hypothesizes that the 'low-viscosity' test fibres PHGG and Gum Arabic provide blood glucose regulation / control comparable to the positive control, Psyllium Husk, while causing fewer severe symptoms comparable to the negative control, Water.

ICD-10 Classifications

Attention to gastrostomy
Gastrostomy status
Other gastritis
Gastritis, unspecified
Gastric diverticulum

Data Source

Australian New Zealand Clinical Trials Registry

ANZCTR12621001646831

Non-Device Trial